[1] 中国高血压防治指南修订委员会.中国高血压防治指南2010[J]. 中华高血压杂志,2011,19(8):701-743. [2] 王文,隋辉,陈伟伟,等.中国高血压防治工作的进步与展望[J]. 中华高血压杂志,2016,24(1):5-6. [3] 国家心血管病中心.《 中国心血管病报告2014》[M].北京:中国大 百科全书出版社,2015:1. [4] Wang J, Zhang L, Wang F,et al. Prevalence, awareness, treatment, and control of hypertension in china: results from a national survey [J]. Am J Hypertens, 2014,27(11): 1355-1361. [5] Jordan J, Yumuk V, Schlaich M, et al. Joint statement of the European association for the study of obesity and the European society of Hypertension: obesity and difficult to treat arterial hypertension [J]. J Hypertens, 2012,30(6): 1047-1055. [6] 符春晖,严华,陆永光,等.原发性高血压病患者肾素-血管紧张 素-醛固酮系统活性的影响因素[J].中华实用诊断与治疗杂志, 2011,25(7):633-635. [7] Goldstein D. Plasma catecholamines and essential hyperten-sion: an analytical review [J]. Hypertension, 1983,5(1):86-89. [8] Yoon S, Gu Q, Nwankwo T,et al. Trends in blood pressure among adults with hypertension: United States, 2003to 2012[J]. Hypertension, 2015,65(1):54-61. [9] Wang Z, Chen Z, Zhang L,et al. Status of hypertension in China: results from the China hypertension survey, 2012—2015[J]. Circulation, 2018,137(22):2344-2356. [10] Domanski M, Mitchell G, Pfeffer M,et al. Pulse pres-sure and cardiovascular disease related mortality: follow-up study of the multiple risk factor intervention trial [J]. JA-MA,2002,287(20):2677-2683. [11] Martell-Claros N, Galgo-Nafria A, OPENJOVEN study group. Cardiovascular risk profile of young hyertensive pa-tients: the OPENJOVEN study [J]. Eur J Prev Cardiol, 2012,19(3):534-540. [12] Rimoldi S, Scherrer U, Messerli F. Secondary arterial hy-pertension:when, who, and how to screen [J]. Eur Heart J, 2014,35(19):1245-1254. [13]中国高血压防治指南修订委员会.中国高血压防治指南(2018年 修订版)[J].中国心血管杂志,2019,24(1):24-56. [14] Williams B, Mancia G, Spiering W,et al. 2018 ESC/ ESH guidelines for the management of arterial hyperten-sion [J]. Eur Heart J, 2018,39(33):3021-3104. [15] Whelton PK, Carey RM, Aronow WS,et al. ACC/AHA/ AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PC-NAguideline for the prevention, detection, evaluation,and management of high blood pressure in adults: a report of the American College of Cardiology/America Heart Associ-ation task force on clinical practice guidelines [J]. Hyper-tension, 2018,71(6):e13-e115. [16] Daskalopoulou S, Rabi D, Zarnke K, et al. The 2015Ca-nadian Hypertension Education Program recommendations for blood pressure measurement,diagnosis, assessment of risk, prevention, and treatment of hypertension [J]. Can J Cardiol,2015,31(5):549-568. [17] Shimamoto K, Ando K, Fujita T, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014) [J]. Hypertens Res, 2014,37(4): 253-392. [18] Allen N, Berry JD, Ning H,et al. Impact of blood pres-sure and blood pressure change during middle age on the remaining lifetime risk for cardiovascular disease: the car-diovascular lifetime risk pooling project [J]. Circulation, 2011,125(1):37-44. [19] 金美华,蒋惠芳,陈丽萍.中青年单纯性舒张期高血压的临床特点 及防治[J].中国社区医师,2012,14(36):155-156. [20] SPRINT research group, Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control [J]. N EngI J Med, 2015,373(22): 2103-2116. [21] 《中国高血压基层管理指南》修订委员会.中国高血压基层管理指 南(2014年修订版)[J].中华高血压杂志,2015,23(1):24-43. [22] 刘靖.高血压治疗:基于血压水平,还是基于风险[J].中华高血压 杂志,2017,25(2):108-110. [23] Piepoli M, Hoes A, Agewall S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice [J]. Eur Heart J,2016,37(29):2315-2381.[24] Laragh J, Sealey J. The plasma renin test reveals the con-tribution of body sodium- volume content (V) and renin-angiotensin(R) vasoconstriction to long-term blood pressure [J]. Am J Hypertens, 2011,24(11):1164-1180. [25] Brown M, Cruickshank J, Dominiczak A,et al. Executive Committee, British Hypertension Society. Better blood pressure control: how to combine drugs [J]. J Hum Hyper-tens, 2003,17(2):81-86. [26] Williams B, Poulter N, Brown M, et al. British hyperten-sion society guidelines for hypertension management 2004 (BHS-IV) summary [J]. BMJ, 2004,328(7440):634-640. [27] Materson BJ, Reda DJ, Cushman WC,et al. Single-drug therapy for hypertension in men. A comparison of six anti hypertensive agent with placebo. The department of veter-ans affairs cooperative study group on anti hypertensive agents [J]. N Engl J Med, 1993,328(13):914-921. [28] Weber M, Schiffrin E, White W,et al. Clinical practice guidelines for the management of hypertension in the com-munity [J]. J Clin Hypertens,2014,16(1):14-26. [29] 孙宁玲,霍勇,黄峻.中国高血压患者心率现状调查[J].中华高血 压杂志,2015,23(10):934-939. [30] 霍勇.重视我国中青年高血压患者的管理[J].中华高血压杂志, 2016,24(4):320-323. [31] Wagner A, Sadoun A, Dallongeville J,et al. High blood pressure prevalence and control in a middle- aged French population and their associated factor: the MONA LISA study [J]. J Hypertens, 2011,29(1):43-50. [32] 刘靖,卢新政,陈鲁原,等.中国中青年高血压管理专家共识[J].中 华高血压杂志,2020,28(4):316-324.